Trinity Financial Services, LLC a leading international life settlement firm since 2001, has joined forces with asset managers, expert legal advisors and other industry experts to form a "best-in-class" platform through which sophisticated investors can participate in the life settlement marketplace. With attractive yields uncorrelated to traditional equity and debt markets life settlements have become a recognized alternative asset class in which institutional and high net worth investors have placed billions of dollars of capital…and the market is expanding rapidly.

If you have a serious interest in participating in the life settlement market, earning attractive long-term returns and partnering with industry experts with decades of experience and the know-how to add real value in the form of guidance, selection, management and service with a desire to stand side-by-side with their clients please, complete the form below and one of our representatives will contact you immediately.

The greatest buying opportunity in the last decade exists in the life settlement market today. Current conditions favor the astute investor but this environment will not endure. Upside potential has never been greater in the longevity markets and now is the time to act.

A life settlement is an insurance policy sold by the owner – typically the insured or a trust – for an amount greater than the surrender value of the policy but lower than the face amount of the policy. The purchaser of the life settlement becomes the new owner and beneficiary of the life insurance policy and is responsible for making future premium payments and collecting the death benefit of the insured.

The life settlement market is an outgrowth of the Viatical settlement market, in which policies of the terminally ill – normally those insureds expected to die within two years – are bought and sold. In the life settlement market, however, insureds generally 65 years or older, with medical impairments resulting in life expectancies of about three to fifteen years.

Life settlements typically are sold through licensed providers by insurance brokers and agents. The price providers pay for the life settlements depends generally on the life expectancies estimated by medical examiners after evaluating the medical records of the insured, as well as policy-specific contract characteristics. The more severe the chronic illness of an insured, the lower the life expectancy and, hence, the higher the price paid for the life settlement.

Life settlement securitization has generated a lot of interest in the capital markets. Indeed, some financial institutions have been financing the accumulation of life settlement portfolios that they hope to securitize. The growth of life settlement securitization will depend on: increased clarity and standardization of the general methods for predicting life expectancies of insureds (including release of data on the performance of medical examiners); the transparency of the fees earned by the carious intermediaries in the transactions; the extent to which the life settlement industry provides safeguards regarding the identities, health conditions and financial status of the policyowners; effective industry regulatory oversight and self-policing; the establishment of rating agency standards for assessing the credit risks associated with such transactions; and the pace of the emergence of new initiatives supported by the life insurance industry to provide alternatives to the secondary market for life insurance policies.